Mckinley Capital Management LLC Novo Cure LTD Transaction History

Mckinley Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$31.96 - $56.12 $735,687 - $1.29 Million	-23,019 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$28.72 - $52.63 $80,128 - $146,837	2,790 Added 13.79%	23,019 $771,000
Q3 2018 Nov 08, 2018	BUY	$32.0 - $52.4 $647,328 - $1.06 Million	20,229 New	20,229 $1.06 Million

277

73.2M

1.43M

832K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.